Xenetic Biosciences has engaged Scott Cullison to serve as an executive consultant for business development and to support the advancement of the Company’s DNase-based oncology platform. Cullison currently serves as the Owner/Consultant for Stride BDCOM Consulting.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on XBIO:
